Clinical Genetics, University Hospitals Bristol, Southwell St, Bristol, UK.
University of Bristol, Bristol, UK.
Genet Med. 2019 Apr;21(4):850-860. doi: 10.1038/s41436-018-0259-2. Epub 2018 Sep 24.
Pathogenic variants in KAT6A have recently been identified as a cause of syndromic developmental delay. Within 2 years, the number of patients identified with pathogenic KAT6A variants has rapidly expanded and the full extent and variability of the clinical phenotype has not been reported.
We obtained data for patients with KAT6A pathogenic variants through three sources: treating clinicians, an online family survey distributed through social media, and a literature review.
We identified 52 unreported cases, bringing the total number of published cases to 76. Our results expand the genotypic spectrum of pathogenic variants to include missense and splicing mutations. We functionally validated a pathogenic splice-site variant and identified a likely hotspot location for de novo missense variants. The majority of clinical features in KAT6A syndrome have highly variable penetrance. For core features such as intellectual disability, speech delay, microcephaly, cardiac anomalies, and gastrointestinal complications, genotype- phenotype correlations show that late-truncating pathogenic variants (exons 16-17) are significantly more prevalent. We highlight novel associations, including an increased risk of gastrointestinal obstruction.
Our data expand the genotypic and phenotypic spectrum for individuals with genetic pathogenic variants in KAT6A and we outline appropriate clinical management.
最近发现 KAT6A 的致病性变异是导致综合征性发育迟缓的原因之一。在两年内,被鉴定为致病性 KAT6A 变异的患者数量迅速增加,但尚未报道其完整的临床表型的范围和变异性。
我们通过三种途径获取 KAT6A 致病性变异患者的数据:治疗临床医生、通过社交媒体分发的在线家庭调查以及文献复习。
我们鉴定了 52 例未报告的病例,使已发表病例的总数达到 76 例。我们的结果扩展了致病性变异的基因型谱,包括错义突变和剪接突变。我们对一个致病性剪接突变进行了功能验证,并确定了新生错义变异的可能热点位置。KAT6A 综合征的大多数临床特征的外显率高度可变。对于核心特征,如智力残疾、言语延迟、小头畸形、心脏异常和胃肠道并发症,基因型-表型相关性表明,晚期截断的致病性变异(外显子 16-17)更为常见。我们强调了一些新的关联,包括胃肠道梗阻的风险增加。
我们的数据扩展了 KAT6A 中遗传致病性变异个体的基因型和表型谱,并概述了适当的临床管理方法。